Agility Robotics Announces Strategic Investment and Agreement with Motion Technology Company Schaeffler Group
Agility Robotics, creator of the leading bipedal Mobile Manipulation Robot (MMR) DigitⓇ, today announced during an appearance at global technology conference Web Summit that Schaeffler has made a minority investment in the company. In addition to the investment, the companies have signed an agreement in which Schaeffler, the motion technology company, intends to purchase humanoid robots from Agility Robotics for use across the whole global Schaeffler plant network.
Andreas Schick, Chief Operating Officer of Schaeffler AG, said: “In disruptive times, implementing innovative manufacturing solutions is crucial to be successful. Here, humanoids play an important role. We, at Schaeffler, will integrate this technology into our operations and see the potential to deploy a significant number of humanoids in our global network of 100 plants by 2030. We look forward to the collaboration with Agility Robotics which will accelerate our activities in this field.”
Earlier this year Agility became the first company to formally commercially deploy humanoid robots after signing a multi-year agreement with GXO, the world’s largest pure-play contract logistics provider, to deploy Digit in GXO’s logistics operations. That agreement also became the industry’s first Robots-as-a-Service (RaaS) deployment of humanoid robots.
“We are excited to welcome Schaeffler as a customer and investor, and look forward to delivering value in their operations with Digit,” said Peggy Johnson, Agility Robotics CEO. “While our technology is helping companies like Schaeffler transform their manufacturing, logistics, and warehousing businesses, scaling the use of humanoid robots will require them to work cooperatively with humans and outside of the safety cages they are in today. I am confident that in the next 24 months, Agility will be the first company to deliver a safe humanoid robot that will be able to work alongside people.”
About Agility Robotics
Headquartered in Salem, Oregon, with offices in Pittsburgh, Pennsylvania and Palo Alto, California, Agility Robotics’ mission is to build robot partners that augment the human workforce, ultimately enabling humans to be more human. Agility’s groundbreaking bipedal Mobile Manipulation Robot (MMR) Digit is the first multi-purpose, human-centric robot that is made for work™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113295142/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Group Holdings Inc. Reports Third Quarter 2024 Financial Results13.11.2024 22:59:00 CET | Press release
SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 HighlightsTotal revenues for the three months ended September 30, 2024 were $53 million, representing an increase of 12% from $47 million in the same quarter of 2023. Total revenues for the nine months ended September 30, 2024 was $160 million, representing an increase of 23% from $131 million in the same period of 2023. Income from operations for the three months ended September 30, 2024 was $13 million, representing a decrease by 31% from the same quarter in 2023. This result was impacted by $12.8 million of stock-based compensation expense related to the Company’s listing process. Income from operations for the nine months ended September 30, 2024 was $65.5 million, representing an increase of
Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services13.11.2024 18:00:00 CET | Press release
Altasciences, a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services. This core business supports both preclinical and clinical studies conducted at Altasciences’ facilities, while also offering an extensive standalone solution to meet the diverse needs of clients. By delivering high-quality, flexible bioanalytical services, Altasciences remains dedicated to advancing drug development and empowering clients across every phase of research. For three decades now, Altasciences has taken pride in evolving their solutions to meet the needs of pharmaceutical and biotechnology companies of all sizes, including the expansion of their labs in Seattle, WA, Columbia, MO, and Laval, Québec. Their three state-of-the-art bioanalytical laboratories feature mirrored operations and uniform protocols to maintain consistency and quality across client projects, ensuring reliable, high-quality data regardless of location. This
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment13.11.2024 15:30:00 CET | Press release
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a leader in Everest Group's first-ever Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment 2024. The report assessed 13 providers based on the market impact of their products and their ability to deliver successful, high-quality offerings. Medidata Rave CTMS leads the industry by providing seamless, real-time patient data outputs that transform enrollment tracking and enable faster, data-driven decisions. Offering instant visibility for study teams, Rave CTMS streamlines collaboration, eliminates manual data entry, and accelerates trial timelines with exceptional accuracy. “We are honored to be recognized as the highest leader in CTMS by Everest Group,” said Tom Doyle, chief technology officer, Medidata. “This accolade underscores our unwavering commitment to transforming research and reaffirms our strategy to deliver
China Moutai Showcases Ecology Promotion Practices at the China Pavilion During COP2913.11.2024 15:05:00 CET | Press release
At a side event titled "Ecological Civilization and Beautiful China Practices" during the 2024 UN Climate Change Conference (COP29) in Baku, Azerbaijan, China Moutai showcased its commitment to ecological sustainability and called for greater attention to climate change. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241113718721/en/ Li Wang, General Manager of China Moutai Group, presented at the side event in Baku. (Photo: Business Wire) Li Wang, General Manager of China Moutai Group, emphasized that Chinese modernization is rooted in achieving harmony between humanity and nature. She said that as a representative of China’s liquor industry, Moutai has embraced the principle that "lucid waters and lush mountains are invaluable assets." This philosophy underscores the company’s approach to modernization, which prioritizes environmental stewardship. Wang highlighted Moutai Group’s dedication to leveraging regional ecological
Appeals Court Confirms Conviction of Intercos Korea in Kolmar Korea Tech Theft13.11.2024 15:00:00 CET | Press release
Intercos Korea to be held criminally liable for leaking and misusing Kolmar Korea’s trade secrets Kolmar Korea (KRX: 161890) has won the victory in the remand trial against Intercos Korea, the Korean subsidiary of Italian cosmetics firm Intercos, concerning the misappropriation of its core sunscreen technology. The latest ruling has confirmed Intercos Korea is guilty of stealing Kolmar Korea’s technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241113259255/en/ Kolmar Korea R&D Complex (photo: Kolmar Holdings) The 3-2 Criminal Division of the Suwon District Court sentenced a fine of KRW 5 million on Intercos Korea for breaching the Unfair Competition Prevention and Trade Secret Protection Act on October 18. While the court reduced the fine from an initial KRW 10 million to KRW 5 million, it upheld the conviction of Intercos Korea. The ruling became final as Intercos Korea opted not to file an appeal. Intercos Korea wa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom